Companies / OREGA Biotech
OREGA Biotech
Lyon, France
OREGA Biotech translates cancer science into first-in-class monoclonal antibodies that restore the immune system's ability to recognize and destroy tumors.
OREGA Biotech, based in Lyon, France, has 1 investor on file, among them Kreaxi. Its site was last checked 20 Nov 2026: site answers.
Investors
1 investor on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Venture capital |
More from Kreaxi
50 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (28%), Enterprise Software (18%), Advanced Materials & Chemicals (14%).
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get OREGA Biotech and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Kreaxi adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/orega-biotech.com/investors
# also
GET /v1/companies/orega-biotech.com
GET /v1/companies/orega-biotech.com/news